000			01990 a2200505 4500
005			20250516214015.0
264		0	_c20140926
008			201409s 0 0 eng d
022			_a1530-0307
024	7		_a10.1038/labinvest.2014.69 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhang, Lei
245	0	0	_aThe aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis. _h[electronic resource]
260			_bLaboratory investigation; a journal of technical methods and pathology _cAug 2014
300			_a839-50 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAldosterone _xchemistry
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aCilazapril _xtherapeutic use
650	0	4	_aDialysis Solutions _xchemistry
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Therapy, Combination
650	0	4	_aLymphocytes _xdrug effects
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMale
650	0	4	_aMineralocorticoid Receptor Antagonists _xtherapeutic use
650	0	4	_aPeritoneal Dialysis, Continuous Ambulatory _xadverse effects
650	0	4	_aPeritoneal Fibrosis _xetiology
650	0	4	_aPeritoneum _xdrug effects
650	0	4	_aPeritonitis _xetiology
650	0	4	_aRandom Allocation
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Mineralocorticoid _xchemistry
650	0	4	_aSpironolactone _xtherapeutic use
650	0	4	_aTransforming Growth Factor beta1 _xanalysis
700	1		_aHao, Jian-Bing
700	1		_aRen, Lian-Sheng
700	1		_aDing, Jiu-Li
700	1		_aHao, Li-Rong
773	0		_tLaboratory investigation; a journal of technical methods and pathology _gvol. 94 _gno. 8 _gp. 839-50
856	4	0	_uhttps://doi.org/10.1038/labinvest.2014.69 _zAvailable from publisher's website
999			_c23858097 _d23858097